1. El-Harazi SM, Feldman RM. Control of intra-ocular inflammation associated with cataract surgery.
Curr Opin Ophthalmol 2001;12:4-8.
2. Kato K, Miyake K, Hirano K, Kondo M. Management of postoperative inflammation and dry eye after cataract surgery.
Cornea 2019;38:Suppl 1. S25-33.
3. Bardoloi N, Sarkar S, Pilania A, Das H. Efficacy and safety of dropless cataract surgery.
Indian J Ophthalmol 2020;68:1081-5.
4. Sahu S, Ram J, Bansal R, et al. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
J Cataract Refract Surg 2015;41:2043-8.
5. Miyake K, Ota I, Miyake G, Numaga J. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
J Cataract Refract Surg 2011;37:1581-8.
6. Nagpal M, Lambat S, Mehrotra N, et al. Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy.
Indian J Ophthalmol 2014;62:606-9.
7. DeCroos FC, Afshari NA. Perioperative antibiotics and anti-inflammatory agents in cataract surgery.
Curr Opin Ophthalmol 2008;19:22-6.
8. Heier JS, Topping TM, Baumann W, et al. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.
Ophthalmology 2000;107:2034-8.
9. Chinchurreta Capote AM, Lorenzo Soto M, et al. Comparative study of the efficacy and safety of bromfenac, nepafenac and diclofenac sodium for the prevention of cystoid macular edema after phacoemulsification.
Int J Ophthalmol 2018;11:1210-6.
10. Yuksel B, Karti O, Kusbeci T. Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives.
Clin Ophthalmol 2017;11:2183-90.
11. Chylack LT Jr, Wolfe JK, Singer DM, et al. The lens opacities classification system III. The longitudinal study of cataract study group.
Arch Ophthalmol 1993;111:831-6.
12. Vasavada AR, Desai JP. Stop, chop, chop, and stuff.
J Cataract Refract Surg 1996;22:526-9.
13. Vasavada A, Singh R. Step-by-step chop in situ and separation of very dense cataracts.
J Cataract Refract Surg 1998;24:156-9.
14. Bardoloi N, Sarkar S, Pilania A, Das H. Pure phaco: phacoemulsification without ophthalmic viscosurgical devices.
J Cataract Refract Surg 2020;46:174-8.
15. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.
Am J Ophthalmol 2005;140:509-16.
16. Fu C, Chu N, Yu X, Yao K. Bimanual microincision cataract surgery versus coaxial microincision cataract surgery: a meta-analysis of randomized controlled trials and cohort studies.
J Ophthalmol 2017 2017:3737603.
17. Shentu X, Zhang X, Tang X, Yu X. Coaxial microincision cataract surgery versus standard coaxial small-incision cataract surgery: a meta-analysis of randomized controlled trials.
PLoS One 2016;11:e0146676..
18. Luo L, Lin H, He M, et al. Clinical evaluation of three incision size-dependent phacoemulsification systems.
Am J Ophthalmol 2012;153:831-9.
19. Can I, Takmaz T, Yildiz Y, et al. Coaxial, microcoaxial, and biaxial microincision cataract surgery: prospective comparative study.
J Cataract Refract Surg 2010;36:740-6.
20. Wilczynski M, Supady E, Piotr L, et al. Comparison of surgically induced astigmatism after coaxial phacoemulsification through 1.8 mm microincision and bimanual phacoemulsification through 1.7 mm microincision.
J Cataract Refract Surg 2009;35:1563-9.
21. Alio JL, Rodriguez-Prats JL, Vianello A, Galal A. Visual outcome of microincision cataract surgery with implantation of an Acri. Smart lens.
J Cataract Refract Surg 2005;31:1549-56.
22. Solomon KD, Cheetham JK, DeGryse R, et al. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.
Ophthalmology 2001;108:331-7.
23. Lane SS, Modi SS, Lehmann RP, Holland EJ. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery.
J Cataract Refract Surg 2007;33:53-8.
24. Ke TL, Graff G, Spellman JM, Yanni JM. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers.
Inflammation 2000;24:371-84.
25. Walters T, Raizman M, Ernest P, et al. In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
J Cataract Refract Surg 2007;33:1539-45.
26. Simone JN, Whitacre MM. Effects of anti-inflammatory drugs following cataract extraction.
Curr Opin Ophthalmol 2001;12:63-7.
27. Keates RH, McGowan KA. Clinical trial of flurbiprofen to maintain pupillary dilation during cataract surgery.
Ann Ophthalmol 1984;16:919-21.
28. Gwon A, Vaughan ER, Cheetham JK, DeGryse R. Ocufen (flurbiprofen) in the treatment of ocular pain after radial keratotomy.
CLAO J 1994;20:131-8.
29. Stark WJ, Fagadau WR, Stewart RH, et al. Reduction of pupillary constriction during cataract surgery using suprofen.
Arch Ophthalmol 1986;104:364-6.
30. Keates RH, McGowan KA. The effect of topical indomethacin ophthalmic solution in maintaining mydriasis during cataract surgery.
Ann Ophthalmol 1984;16:1116-21.
31. Koay P. The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology.
Br J Ophthalmol 1996;80:480-5.
32. Arshinoff S, D’Addario D, Sadler C, et al. Use of topical nonsteroidal anti-inflammatory drugs in excimer laser photorefractive keratectomy.
J Cataract Refract Surg 1994;20 Suppl. 216-22.
33. Bucci FA Jr, Waterbury LD. Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.
Adv Ther 2011;28:1089-95.
34. Miyake K, Masuda K, Shirato S, et al. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial.
Jpn J Ophthalmol 2000;44:58-67.
35. Naithani P, Puranik S, Vashisht N, et al. Role of topical nepafenac in prevention and treatment of macular edema after vitreoretinal surgery.
Retina 2012;32:250-5.
36. Flach AJ, Jaffe NS, Akers WA. The effect of ketorolac tromethamine in reducing postoperative inflammation: double-mask parallel comparison with dexamethasone.
Ann Ophthalmol 1989;21:407-11.
37. Simone JN, Pendelton RA, Jenkins JE. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
J Cataract Refract Surg 1999;25:699-704.
38. Brennan KM, Brown RM, Roberts CW. A comparison of topical non-steroidal anti-inflammatory drugs to steroids for control of post cataract inflammation. Insight 1993;18:8-9.
39. Gaynes BI, Fiscella R. Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review.
Drug Saf 2002;25:233-50.